Targeting the silent minority: emerging immunotherapeutic strategies for eradication of malignant stem cells in chronic myeloid leukaemia M. CoplandA. R. FraserT. L. Holyoake Review 30 November 2004 Pages: 297 - 306
Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy Christian BlankThomas F. GajewskiAndreas Mackensen Review 15 December 2004 Pages: 307 - 314
Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft Rosalyn D. BlumenthalLou OsorioDavid M. Goldenberg Original Article 11 December 2004 Pages: 315 - 327
Acquisition of multidrug resistance by L1210 leukemia cells decreases their tumorigenicity and enhances their susceptibility to the host immune response Elena Martín-OrozcoJosé Antonio FerragutAntonio Ferrer-Montiel Original Article 04 December 2004 Pages: 328 - 336
Distribution of labelled anti-tenascin antibodies and fragments after injection into intact or partly resected C6-gliomas in rats Claudia Maria GoetzWalter RachingerHans-Jürgen Reulen Original Article 24 September 2004 Pages: 337 - 344
Heterogeneous antibody response to polyvalent melanoma vaccines in syngeneic mice Dean JohnstonJean-Claude Bystryn Original Article 09 September 2004 Pages: 345 - 350
BCL1 lymphoma protection induced by idiotype DNA vaccination is entirely dependent on anti-idiotypic antibodies Michela Cesco-GaspereFederica BenvenutiOscar R. Burrone Original Article 26 October 2004 Pages: 351 - 358
Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members Kevin T. HoganJennifer N. SuttonCraig L. Slingluff Jr Original Article 16 September 2004 Pages: 359 - 371
Uptake and presentation of malignant glioma tumor cell lysates by monocyte-derived dendritic cells Steven De VleeschouwerMohammed ArredouaniStefaan W. Van Gool Original Article 19 October 2004 Pages: 372 - 382
Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model Michael Y. ShapiraEster HirshfeldShimon Slavin Original Article 03 November 2004 Pages: 383 - 388
Phenotype and function of human natural killer cells purified by using a clinical-scale immunomagnetic method Wing LeungRekha IyengarRupert Handgretinger Original Article 22 September 2004 Pages: 389 - 394
Identification of the protein components of protein-bound polysaccharide (PSK) that interact with NKL cells Eva JiménezAngel Garcia-LoraFederico Garrido Original Article 16 December 2004 Pages: 395 - 399
Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma Matthias WölflAchim A. JungbluthFrank Berthold Short Communication 24 September 2004 Pages: 400 - 406
